Denali Therapeutics Inc. DNLI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $103.85M+6.1% | $97.91M-4.0% | $101.95M-0.7% | $102.7M-11.6% | $116.23M+16.5% | ||
| $33.51M-15.1% | $39.46M+11.2% | $35.48M+10.0% | $32.27M+9.9% | $29.35M-2.3% | ||
| $137.36M0.0% | $137.37M-0.1% | $137.43M+1.8% | $134.96M-7.3% | $145.58M+12.1% | ||
| -$137.36M0.0% | -$137.37M+0.1% | -$137.43M-1.8% | -$134.96M+7.3% | -$145.58M-12.1% | ||
| -$128.45M+0.1% | -$128.55M-1.3% | -$126.9M-2.2% | -$124.12M+6.7% | -$132.97M-15.9% | ||
| -$0.69+5.5% | -$0.73+1.4% | -$0.74-2.8% | -$0.72+7.7% | -$0.78-14.7% | ||
| -$134.51M0.0% | -$134.5M0.0% | -$134.49M-1.9% | -$131.92M+7.9% | -$143.26M-11.9% | ||
| -$137.36M0.0% | -$137.37M+0.1% | -$137.43M-1.8% | -$134.96M+7.3% | -$145.58M-12.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Denali Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Denali Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.